Mounjaro Without Injection: Is There an Alternative Form?

Mounjaro (tirzepatide) is licensed only as a once-weekly subcutaneous injection — no oral form exists in the UK as of summer 2026.
The Mounjaro KwikPen is pre-filled and pre-set, with a small concealed needle; most people find the injection far less daunting than they expected.
Oral semaglutide (Wegovy tablets) became the UK's first oral GLP-1 weight-loss medicine in June 2026, a different drug on a different mechanism, but the closest licensed alternative for those who cannot tolerate injections.
Needle anxiety is one of the most common concerns our prescribers hear; injection technique, site rotation and prep steps can make a significant practical difference.

Mounjaro is currently only available as a subcutaneous injection — there is no oral tablet, capsule or patch version licensed in the UK. Each KwikPen delivers one weekly dose under the skin, and that single-route delivery is how tirzepatide's dual GIP and GLP-1 mechanism is designed to work. If injections feel like a barrier, it is worth understanding what the process actually involves before ruling them out. These are prescription-only medicines; a GPhC-registered prescriber assesses suitability before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to approach Mounjaro treatment if you are anxious about injecting

Step 1: Understand exactly what the Mounjaro injection involves

The Mounjaro KwikPen is not a traditional syringe. It is a pre-filled, pre-dosed auto-injector with a small concealed needle, you press it against the skin and activate it; you do not handle or see the needle during use. The pen delivers one fixed dose, covers four weekly injections per pen, and then it is done. Most people are genuinely surprised by how minor the sensation is.

Treatment starts at 2.5mg, a tolerability dose that lets your body adjust gradually. The first pen's job is settling your system, not driving weight loss immediately; nausea at this stage is common but usually mild. You can read more about how the Mounjaro injection works and the full pen range on the Mounjaro injection pens page.

Injection sites are the abdomen, thigh or upper arm; you rotate between them each week to reduce localised irritation. Correct rotation matters more than most people realise, and the guidance on site selection covers the detail. One practical note: cleaning the skin with an alcohol swab before each injection is straightforward and takes seconds, alcohol swabs are available from our pharmacy if you need them.

The NHS medicines information for tirzepatide is a reliable first reference if you want to read the full list of what to expect before you start: NHS tirzepatide patient information.

Step 2: Work on technique rather than avoidance

Needle anxiety is real, and our prescribers hear about it most weeks. It rarely goes away by reading more about it, it responds better to doing it correctly once. The practical steps that make a difference: inject at room temperature rather than straight from the fridge, choose a fleshy site where the skin has some give, keep the pen firmly in contact with the skin for the full duration of the injection, and breathe out as you press. Small things, but they change the experience noticeably.

Bruising and soreness are the most common physical complaints, and both are almost always technique-related rather than inevitable. The step-by-step guide to injecting without bruising goes through each variable in detail. It is genuinely worth reading before your first injection rather than after.

If you are concerned about the physical process, raise it during your consultation. A prescriber can walk through the technique and, where appropriate, connect you with aftercare support. Injection anxiety is not a reason to skip clinical assessment, it is exactly the kind of thing the process exists to address.

Step 3: Know the only licensed oral alternative

If injections remain a hard barrier after understanding the full picture, the alternative to consider is Wegovy tablets. On 11 June 2026, the MHRA approved oral semaglutide (Wegovy) as the first GLP-1 medicine licensed in tablet form for weight management in the UK, making Britain the first country in Europe to do so.

It is a different drug from tirzepatide. Wegovy tablets contain semaglutide, a single GLP-1 receptor agonist rather than tirzepatide's dual GIP/GLP-1 action. Trial data from the OASIS 4 study reported around 13.6% average weight loss at 64 weeks, rising to roughly 17% among participants who adhered fully to treatment, the latter figure is specifically the fully-adherent group, not the population average. The tablet is taken once daily, first thing in the morning on an empty stomach, with a small amount of plain water, at least 30 minutes before food or other oral medicines. No refrigeration is needed, which does make it more straightforward for travel and day-to-day routine.

For a broader comparison of the two medicines and how each fits different circumstances, the weight-loss treatment overview sets out what is currently available through nume. Eligibility for each medicine differs; it is a clinical decision, not a product preference.

For context on how private treatment pricing works, the recent Mounjaro pricing changes page explains how Eli Lilly's list-price adjustment affects private costs, useful background if cost is part of your thinking alongside route of administration.

Step 4: Talk to a prescriber before deciding

The right medicine and route for you depends on your health history, current medications and personal circumstances, not just the delivery format. A prescriber needs to see the whole picture before recommending tirzepatide, Wegovy tablets or anything else. That means a proper clinical assessment, not a tick-box form.

At nume, every consultation is read by a real clinician on the day it is submitted, not processed by software. If you order before 12pm on a working day and your application is approved, treatment is dispatched the same day and arrives the next working day with DPD, in plain unbranded packaging. The consultation is free, and so is the prescription if treatment goes ahead.

To learn more about what the Mounjaro treatment involves in full, or to look at what else is available, our FAQs cover the most common questions. When you are ready, you can speak to our prescribers, the consultation takes a few minutes and there is no obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions